These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10823343)

  • 1. Enhancement in extracellular serotonin levels by 5-hydroxytryptophan loading after administration of WAY 100635 and fluoxetine.
    Dreshfield-Ahmad LJ; Thompson DC; Schaus JM; Wong DT
    Life Sci; 2000 Apr; 66(21):2035-41. PubMed ID: 10823343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935.
    Gobert A; Rivet JM; Cistarelli L; Millan MJ
    J Neurochem; 1997 Mar; 68(3):1159-63. PubMed ID: 9048762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors.
    Barton CL; Hutson PH
    Synapse; 1999 Jan; 31(1):13-9. PubMed ID: 10025679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex.
    Invernizzi R; Bramante M; Samanin R
    Pharmacol Biochem Behav; 1996 May; 54(1):143-7. PubMed ID: 8728551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of pre- and post-synaptic 5-HT1A receptors does not modify the effect of fluoxetine or 5-hydroxytryptophan on ethanol and food intake in rats.
    Ciccocioppo R; Panocka I; Polidori C; Dourish CT; Massi M
    Psychopharmacology (Berl); 1997 Nov; 134(1):55-63. PubMed ID: 9399367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine.
    Li XM; Perry KW; Wong DT
    Chin J Physiol; 1999 Jun; 42(2):53-9. PubMed ID: 10513599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum corticosterone increases reflect enhanced uptake inhibitor-induced elevation of extracellular 5-hydroxytryptamine in rat hypothalamus.
    Fuller RW; Perry KW; Hemrick-Luecke SK; Engleman E
    J Pharm Pharmacol; 1996 Jan; 48(1):68-70. PubMed ID: 8722499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study.
    Malagié I; Trillat AC; Douvier E; Anmella MC; Dessalles MC; Jacquot C; Gardier AM
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Dec; 354(6):785-90. PubMed ID: 8971740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic neurochemical and behavioral effects of fluoxetine and 5-HT1A receptor antagonists.
    Trillat AC; Malagié I; Mathe-Allainmat M; Anmella MC; Jacquot C; Langlois M; Gardier AM
    Eur J Pharmacol; 1998 Sep; 357(2-3):179-84. PubMed ID: 9797034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo.
    Sharp T; Umbers V; Gartside SE
    Br J Pharmacol; 1997 Jul; 121(5):941-6. PubMed ID: 9222551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive reduction of alcohol drinking by 5-HT1A antagonist WAY 100635 and serotonin uptake blocker fluoxetine in alcohol-preferring P rats.
    Zhou FC; McKinzie DL; Patel TD; Lumeng L; Li TK
    Alcohol Clin Exp Res; 1998 Feb; 22(1):266-9. PubMed ID: 9514317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors.
    Hervás I; Artigas F
    Eur J Pharmacol; 1998 Sep; 358(1):9-18. PubMed ID: 9809863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol.
    Dawson LA; Nguyen HQ
    Neuropharmacology; 2000 Apr; 39(6):1044-52. PubMed ID: 10727715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA; Nguyen HQ; Smith DL; Schechter LE
    J Psychopharmacol; 2002 Jun; 16(2):145-52. PubMed ID: 12095073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pindolol, a putative 5-hydroxytryptamine(1A) antagonist, does not reverse the inhibition of serotonergic neuronal activity induced by fluoxetine in awake cats: comparison to WAY-100635.
    Fornal CA; Martin FJ; Metzler CW; Jacobs BL
    J Pharmacol Exp Ther; 1999 Oct; 291(1):220-8. PubMed ID: 10490908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors.
    Dreshfield LJ; Wong DT; Perry KW; Engleman EA
    Neurochem Res; 1996 May; 21(5):557-62. PubMed ID: 8726963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific serotonin reuptake inhibitor-induced decreases in lymphocyte activity require endogenous serotonin release.
    Pellegrino TC; Bayer BM
    Neuroimmunomodulation; 2000; 8(4):179-87. PubMed ID: 11251392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serotonin-1A receptor antagonist WAY-100635 modifies fluoxetine's antidepressant-like profile on the differential reinforcement of low rates 72-s schedule in rats.
    Cousins MS; Seiden LS
    Psychopharmacology (Berl); 2000 Mar; 148(4):438-42. PubMed ID: 10928318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of central corticosteroid receptors following short-term activation of serotonin transmission by 5-hydroxy-L-tryptophan or fluoxetine.
    Sémont A; Fache M; Héry F; Faudon M; Youssouf F; Héry M
    J Neuroendocrinol; 2000 Aug; 12(8):736-44. PubMed ID: 10929085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.